FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2768310080> ?p ?o ?g. }

• W2768310080 endingPage "2206" @default.
• W2768310080 startingPage "2198" @default.
• W2768310080 abstract "Agents targeting epidermal growth factor receptor (EGFR) are used to treat head and neck squamous cell carcinoma (HNSCC); however, their efficacy and safety is poorly understood. Here we evaluated the efficacy and safety of anti‐EGFR agents administered concurrently with standard therapies for HNSCC. Randomized controlled trials that evaluated addition of EGFR targeted therapy versus standard therapy alone were included. The primary outcome was overall survival (OS). Secondary outcomes were progression‐free survival (PFS), overall response rate (ORR), locoregional control, and severe adverse events (SAEs, grade ≥ 3). Sixteen eligible trials with 4031 patients were included. Addition of anti‐EGFR regimens to standard therapy significantly improved OS of patients with HNSCC (HR = 0.89; 95% CI, 0.82–0.96), with a moderately elevated rate of SAEs (RR = 1.08; 95% CI, 1.03–1.13). Subgroup analysis indicated that the survival benefit was observed when cetuximab was administered concurrently with radiotherapy (RT) for stage III/IV patients (HR = 0.76; 95% CI, 0.61–0.94; p = 0.01), or with chemotherapy for recurrent or metastatic (R/M) HNSCC (HR = 0.86; 95% CI, 0.78–0.95; p = 0.005). Significantly increased ORR (RR = 1.51; 95% CI 1.05–2.18) and PFS (HR = 0.72; 95% CI, 0.59–0.88) were found in R/M HNSCC patients treated with anti‐EGFR plus chemotherapy, while no significant improvements were found in stage III/IV patients treated with anti‐EGFR plus standard therapy. In conclusion, addition of cetuximab to standard therapy may improve outcomes for R/M HNSCC patients, while causing a moderate increase in SAEs. For stage III/IV patients, anti‐EGFR mAb plus RT can improve OS compared with RT alone, while replacement of chemotherapy with EGFR mAb or adding EGFR mAb to combined chemotherapy and RT did not improve outcomes." @default.
• W2768310080 created "2017-12-04" @default.
• W2768310080 creator A5020482090 @default.
• W2768310080 creator A5041113040 @default.
• W2768310080 creator A5056810676 @default.
• W2768310080 creator A5064310614 @default.
• W2768310080 creator A5081833350 @default.
• W2768310080 creator A5082641190 @default.
• W2768310080 creator A5085127294 @default.
• W2768310080 creator A5085965802 @default.
• W2768310080 date "2017-11-27" @default.
• W2768310080 modified "2023-10-17" @default.
• W2768310080 title "Efficacy and safety of anti-EGFR agents administered concurrently with standard therapies for patients with head and neck squamous cell carcinoma: a systematic review and meta-analysis of randomized controlled trials" @default.
• W2768310080 cites W1535136055 @default.
• W2768310080 cites W1841144092 @default.
• W2768310080 cites W1977490616 @default.
• W2768310080 cites W1979423827 @default.
• W2768310080 cites W1982167700 @default.
• W2768310080 cites W2003198224 @default.
• W2768310080 cites W2017663824 @default.
• W2768310080 cites W2023807845 @default.
• W2768310080 cites W2029032030 @default.
• W2768310080 cites W2049050498 @default.
• W2768310080 cites W2053424592 @default.
• W2768310080 cites W2062424471 @default.
• W2768310080 cites W2070082457 @default.
• W2768310080 cites W2073541926 @default.
• W2768310080 cites W2079228270 @default.
• W2768310080 cites W2090190093 @default.
• W2768310080 cites W2093207065 @default.
• W2768310080 cites W2101027485 @default.
• W2768310080 cites W2105499507 @default.
• W2768310080 cites W2112845420 @default.
• W2768310080 cites W2121869934 @default.
• W2768310080 cites W2122503228 @default.
• W2768310080 cites W2122524064 @default.
• W2768310080 cites W2123548341 @default.
• W2768310080 cites W2145070131 @default.
• W2768310080 cites W2146488048 @default.
• W2768310080 cites W2148834247 @default.
• W2768310080 cites W2151730005 @default.
• W2768310080 cites W2154152644 @default.
• W2768310080 cites W2158134441 @default.
• W2768310080 cites W2167685509 @default.
• W2768310080 cites W2170242096 @default.
• W2768310080 cites W2194286561 @default.
• W2768310080 cites W2341933843 @default.
• W2768310080 cites W2385773132 @default.
• W2768310080 cites W2464944724 @default.
• W2768310080 cites W2576440140 @default.
• W2768310080 cites W2622219590 @default.
• W2768310080 cites W3190062375 @default.
• W2768310080 cites W950232622 @default.
• W2768310080 doi "https://doi.org/10.1002/ijc.31157" @default.
• W2768310080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29143328" @default.
• W2768310080 hasPublicationYear "2017" @default.
• W2768310080 type Work @default.
• W2768310080 sameAs 2768310080 @default.
• W2768310080 citedByCount "23" @default.
• W2768310080 countsByYear W27683100802018 @default.
• W2768310080 countsByYear W27683100802019 @default.
• W2768310080 countsByYear W27683100802020 @default.
• W2768310080 countsByYear W27683100802021 @default.
• W2768310080 countsByYear W27683100802022 @default.
• W2768310080 countsByYear W27683100802023 @default.
• W2768310080 crossrefType "journal-article" @default.
• W2768310080 hasAuthorship W2768310080A5020482090 @default.
• W2768310080 hasAuthorship W2768310080A5041113040 @default.
• W2768310080 hasAuthorship W2768310080A5056810676 @default.
• W2768310080 hasAuthorship W2768310080A5064310614 @default.
• W2768310080 hasAuthorship W2768310080A5081833350 @default.
• W2768310080 hasAuthorship W2768310080A5082641190 @default.
• W2768310080 hasAuthorship W2768310080A5085127294 @default.
• W2768310080 hasAuthorship W2768310080A5085965802 @default.
• W2768310080 hasBestOaLocation W27683100801 @default.
• W2768310080 hasConcept C121608353 @default.
• W2768310080 hasConcept C126322002 @default.
• W2768310080 hasConcept C143998085 @default.
• W2768310080 hasConcept C168563851 @default.
• W2768310080 hasConcept C197934379 @default.
• W2768310080 hasConcept C2776530083 @default.
• W2768310080 hasConcept C2776694085 @default.
• W2768310080 hasConcept C2776833033 @default.
• W2768310080 hasConcept C2777506169 @default.
• W2768310080 hasConcept C2779438470 @default.
• W2768310080 hasConcept C2779998722 @default.
• W2768310080 hasConcept C509974204 @default.
• W2768310080 hasConcept C526805850 @default.
• W2768310080 hasConcept C71924100 @default.
• W2768310080 hasConcept C95190672 @default.
• W2768310080 hasConceptScore W2768310080C121608353 @default.
• W2768310080 hasConceptScore W2768310080C126322002 @default.
• W2768310080 hasConceptScore W2768310080C143998085 @default.
• W2768310080 hasConceptScore W2768310080C168563851 @default.
• W2768310080 hasConceptScore W2768310080C197934379 @default.
• W2768310080 hasConceptScore W2768310080C2776530083 @default.
• W2768310080 hasConceptScore W2768310080C2776694085 @default.
• W2768310080 hasConceptScore W2768310080C2776833033 @default.

• next